文献速递头颈部肿瘤放疗放疗物理与技术

头颈部癌根治性放疗中在线自适应放疗的早期经验

Early Experience of Online Adaptive Radiation Therapy for Definitive Radiation of Patients With Head and Neck Cancer.
PubMed 文献 · Adv Radiat Oncol · 2023-04-26

该前瞻性注册研究纳入接受根治性标准分割放化疗且至少进行1次在线自适应放疗(oART)的头颈部癌患者,评估oART可行性。21例患者共进行43次自适应治疗,自适应计划在93%的情况下被选用;自适应计划较计划计划显著提高各风险靶区覆盖并降低热点,多个危及器官剂量降低。

要点

  • 自适应计划在93%的自适应治疗中被选用。
  • 高危、中危、低危PTV接受100%处方剂量的平均体积自适应计划均高于计划计划(P < .01)。
  • 自适应计划平均热点更低(108.8% vs 106.4%,P < .01),多个危及器官剂量显著降低。

核心结论

  • 在线自适应放疗对头颈部癌可行,靶区覆盖和均匀性显著改善,多个危及器官剂量适度降低。

研究设计与样本

  • 前瞻性注册研究,纳入接受根治性标准分割放化疗且至少进行1次oART的头颈部癌患者21例。
  • 自适应频率由治疗医生决定;自适应时可选择将原始计划映射到锥形束CT并调整轮廓的计划计划或根据更新轮廓生成的新自适应计划。

主要发现

  • 21例患者(15例口咽、4例喉/下咽、2例其他)共进行43次自适应治疗(中位数2次)。
  • 自适应流程时间中位数23分钟,医生在控制台时间中位数27分钟,患者在治疗室内时间中位数43.5分钟。
  • 自适应计划选用率93%。
  • 高危PTV接受100%处方剂量的平均体积:计划计划87.8% vs 自适应计划95%(P < .01);中危PTV:87.3% vs 97.9%(P < .01);低危PTV:94% vs 97.8%(P < .01)。
  • 平均热点:计划计划108.8% vs 自适应计划106.4%(P < .01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The advent of cone beam computed tomography-based online adaptive radiation therapy (oART) has dramatically reduced the barriers of adaptation. We present the first prospective oART experience data in radiation of head and neck cancers (HNC). METHODS AND MATERIALS: Patients with HNC receiving definitive standard fractionation (chemo)radiation who underwent at least 1 oART session were enrolled in a prospective registry study. The frequency of adaptations was at the discretion of the treating physician. Physicians were given the option of delivering 1 of 2 plans during adaptation: the original radiation plan transposed onto the cone beam computed tomography with adapted contours (scheduled), and a new adapted plan generated from the updated contours (adapted). A paired t test was used to compare the mean doses between scheduled and adapted plans. RESULTS: Twenty-one patients (15 oropharynx, 4 larynx/hypopharynx, 2 other) underwent 43 adaptation sessions (median, 2). The median ART process time was 23 minutes, median physician time at the console was 27 minutes, and median patient time in the vault was 43.5 minutes. The adapted plan was chosen 93% of the time. The mean volume in each planned target volume (PTV) receiving 100% of the prescription dose for the scheduled versus adapted plan for high-risk PTVs was 87.8% versus 95% (P < .01), intermediate-risk PTVs was 87.3% versus 97.9% (P < .01), and low-risk PTVs was 94% versus 97.8% (P < .01), respectively. The mean hotspot was also lower with adaptation: 108.8% versus 106.4% (P < .01). All but 1 organ at risk (11/12) saw a decrease in their dose with the adapted plans, with the mean ipsilateral parotid (P = .013), mean larynx (P < .01), maximum point spinal cord (P < .01), and maximum point brain stem (P = .035) reaching statistical significance. CONCLUSIONS: Online ART is feasible for HNC, with significant improvement in target coverage and homogeneity and a modest decrease in doses to several organs at risk.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Avkshtol V, Meng B, Shen C, et al. Early Experience of Online Adaptive Radiation Therapy for Definitive Radiation of Patients With Head and Neck Cancer. Adv Radiat Oncol. 2023. PMID: 37408672. doi:10.1016/j.adro.2023.101256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。